| __timestamp | Bristol-Myers Squibb Company | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5699000000 | 44820000 |
| Thursday, January 1, 2015 | 5001000000 | 82080000 |
| Friday, January 1, 2016 | 5002000000 | 97130000 |
| Sunday, January 1, 2017 | 4849000000 | 121271000 |
| Monday, January 1, 2018 | 4551000000 | 153548000 |
| Tuesday, January 1, 2019 | 4871000000 | 202541000 |
| Wednesday, January 1, 2020 | 7661000000 | 245164000 |
| Friday, January 1, 2021 | 7690000000 | 285773000 |
| Saturday, January 1, 2022 | 7814000000 | 325998000 |
| Sunday, January 1, 2023 | 7772000000 | 332540000 |
| Monday, January 1, 2024 | 8414000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Bristol-Myers Squibb Company and PTC Therapeutics, Inc. from 2014 to 2023. Over this period, Bristol-Myers Squibb consistently outspent PTC Therapeutics, with its SG&A expenses peaking in 2022 at approximately 7.8 billion dollars, a 72% increase from 2014. In contrast, PTC Therapeutics saw a more modest rise, with expenses growing by over 640% to reach around 332 million dollars in 2023. This stark difference highlights the scale and operational strategies of these companies. While Bristol-Myers Squibb's substantial investments reflect its expansive market reach, PTC Therapeutics' growth trajectory underscores its strategic focus on innovation and niche markets.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company or Zoetis Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Neurocrine Biosciences, Inc.
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?